Dec 19 Prometheus Laboratories Inc filed with
U.S. regulators on Wednesday to raise up to $100 million in an
initial public offering of common stock.
The San Diego, California-based specialty pharmaceutical
company told the U.S Securities and Exchange Commission in a
preliminary prospectus that Goldman Sachs & Co, Credit Suisse
and Cowen and Co were underwriting the IPO.
The filing did not reveal how many shares the company
planned to sell or their expected price.
(Reporting by Niveditha Ravi in Bangalore; Editing by Amitha
Rajan) ((email@example.com; within U.S +1 646 223
8780; outside U.S. +91 80 4135 5800; Reuters Messaging